SCHEMBL184102

SCHEMBL184102

O=C1COCC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL11610685 0.84 CRBN (0.38)
Bicarbonate SCHEMBL11610677 0.84 CRBN (0.38)
Bicarbonate SCHEMBL11610675 0.82 CRBN (0.36)
SCHEMBL6064325 0.80
SCHEMBL5161198 0.70
SCHEMBL17043 0.68
SCHEMBL9542421 0.67 GAA (0.73)
SCHEMBL123971 0.67
SCHEMBL962066 0.67
SCHEMBL4119295 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115329-A1 BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-04-30 US claimed
WO-2026090380-A1 BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-04-30 WO claimed
US-20250345488-A1 CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-11-13 US claimed
CN-119101069-A Spiro compounds and uses thereof 轩竹生物科技股份有限公司 2024-12-10 CN claimed
CN-112684070-B Method for measuring semi-volatile organic compounds in solid waste 山东微谱检测技术有限公司 2024-05-24 CN claimed
CN-112684070-A Method for measuring semi-volatile organic compounds in solid waste 山东微谱检测技术有限公司 2021-04-20 CN claimed
CN-111801333-A 10- (di (phenyl) methyl) -4-hydroxy-8, 9,9a, 10-tetrahydro-7H-pyrrolo [1',2':4,5] pyrazino [1,2-b ] pyridazine-3, 5-dione derivatives and related compounds as inhibitors of orthomyxovirus replication for the treatment of influenza 诺华股份有限公司 2020-10-20 CN claimed
US-10160764-B2 Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections NOVARTIS AG (CH) 2018-12-25 US claimed
CN-101981035-B Salts of triazoles as PAR1 inhibitors, their preparation and their use as medicaments SANOFI AVENTIS 2013-08-28 CN claimed
JP-4778449-B2 2011-09-21 JP claimed
WO-1999009041-A2 SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AVECIA LIMITED (GB) 1999-02-25 WO claimed
EP-0510028-B1 THIOFORMAMIDE DERIVATIVES RHONE POULENC RORER SA (FR) 1995-03-15 EP claimed
CN-1027271-C Preparation method of n-statinib and n-cyclostatini polypeptide PFICER CO LTD (US) 1995-01-04 CN claimed
EP-0266950-B1 Nor-statine and nor-cyclostatine polypeptides PFIZER (US) 1993-12-29 EP claimed
EP-0510028-A1 THIOFORMAMIDE DERIVATIVES. RHONE POULENC RORER SA (FR) 1992-10-28 EP claimed
EP-0473337-A2 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma PFIZER INC. (US) 1992-03-04 EP claimed
WO-1991010652-A1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1991-07-25 WO claimed
US-5034376-A Nor-statine and nor-cyclostatine polypeptides PFIZER INC. (US) 1991-07-23 US claimed
EP-0266950-A2 Nor-statine and nor-cyclostatine polypeptides PFIZER INC. (US) 1988-05-11 EP claimed
CN-87101499-A Preparation method of n-statinib and n-cyclostatini polypeptide 1988-05-11 CN claimed